Sepsis Induced Hypotension clinical trials

Explore recruiting sepsis induced hypotension clinical trials.

Also recruiting in Europe

Sepsis Induced Hypotension trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamic Effects of REGN7544, an Antagonist Monoclonal Antibody to NPR1, in Patients with Sepsis-Induced Hypotension

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Sepsis Induced Hypotension trials by city

Sepsis Induced Hypotension in Toronto Sepsis Induced Hypotension in Vancouver Sepsis Induced Hypotension in Montreal Sepsis Induced Hypotension in Calgary Sepsis Induced Hypotension in Edmonton Sepsis Induced Hypotension in Ottawa Sepsis Induced Hypotension in Winnipeg Sepsis Induced Hypotension in Quebec City Sepsis Induced Hypotension in Hamilton Sepsis Induced Hypotension in Kitchener Sepsis Induced Hypotension in London Sepsis Induced Hypotension in Halifax Sepsis Induced Hypotension in New York Sepsis Induced Hypotension in Los Angeles Sepsis Induced Hypotension in Chicago Sepsis Induced Hypotension in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease